Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: Results from the SMART SF trial
EP Europace Aug 18, 2017
Chinitz LA, et al. – Periprocedural safety, acute effectiveness, and procedural efficiency of a novel catheter, the THERMOCOOL SMARTTOUCH SF Catheter, for drug–refractory symptomatic paroxysmal atrial fibrillation (PAF) ablation was assessed in the SMART SF study. Findings demonstrated the safety as well as acute efficacy of the THERMOCOOL SMARTTOUCH SF Catheter for PAF ablation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
